Estonia Weighing Drug Coverage Expansion

The Estonian Health Insurance Fund (EHIF) is evaluating whether to extend coverage for a diabetes drug to individuals with obesity. This decision is based on a cost-benefit analysis that will be completed in the autumn. The move could significantly impact access to medication for a larger segment of the population.

Summarized from the sources above. Read the originals for the full story.